Canada Markets open in 1 hr 49 mins

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.83-0.17 (-0.50%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.26
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 371.25
52 Week Low 329.74
50-Day Moving Average 335.14
200-Day Moving Average 336.78

Share Statistics

Avg Vol (3 month) 3536.67k
Avg Vol (10 day) 3367.26k
Shares Outstanding 5140.31M
Implied Shares Outstanding 6N/A
Float 892.3M
% Held by Insiders 11.31%
% Held by Institutions 182.98%
Shares Short (Jul. 29, 2021) 44.75M
Short Ratio (Jul. 29, 2021) 49.17
Short % of Float (Jul. 29, 2021) 44.36%
Short % of Shares Outstanding (Jul. 29, 2021) 43.38%
Shares Short (prior month Jun. 29, 2021) 44.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021

Profitability

Profit Margin -128.33%
Operating Margin (ttm)-129.16%

Management Effectiveness

Return on Assets (ttm)-11.41%
Return on Equity (ttm)-28.00%

Income Statement

Revenue (ttm)133.43M
Revenue Per Share (ttm)0.97
Quarterly Revenue Growth (yoy)83.50%
Gross Profit (ttm)-40.22M
EBITDA -162.26M
Net Income Avi to Common (ttm)-171.23M
Diluted EPS (ttm)-1.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)598.41M
Total Cash Per Share (mrq)4.25
Total Debt (mrq)108.61M
Total Debt/Equity (mrq)15.66
Current Ratio (mrq)5.52
Book Value Per Share (mrq)5.19

Cash Flow Statement

Operating Cash Flow (ttm)-182.46M
Levered Free Cash Flow (ttm)-110.2M